Microbiology

  1. ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model

    1. Koen Vandyck
    2. Rana Abdelnabi
    3. Kusum Gupta
    4. Dirk Jochmans
    5. Andreas Jekle
    6. Jerome Deval
    7. Dinah Misner
    8. Dorothée Bardiot
    9. Caroline S. Foo
    10. Cheng Liu
    11. Suping Ren
    12. Leonid Beigelman
    13. Lawrence M. Blatt
    14. Sandro Boland
    15. Laura Vangeel
    16. Steven Dejonghe
    17. Patrick Chaltin
    18. Arnaud Marchand
    19. Vladimir Serebryany
    20. Antitsa Stoycheva
    21. Sushmita Chanda
    22. Julian A. Symons
    23. Pierre Raboisson
    24. Johan Neyts

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Sex differences in lung imaging and SARS-CoV-2 antibody responses in a COVID-19 golden Syrian hamster model

    1. Santosh Dhakal
    2. Camilo A. Ruiz-Bedoya
    3. Ruifeng Zhou
    4. Patrick S. Creisher
    5. Jason S. Villano
    6. Kirsten Littlefield
    7. Jennie Ruelas Castillo
    8. Paula Marinho
    9. Anne Jedlicka
    10. Alvaro A. Ordonez
    11. Natalia Majewski
    12. Michael J. Betenbaugh
    13. Kelly Flavahan
    14. Alice L. Mueller
    15. Monika M. Looney
    16. Darla Quijada
    17. Filipa Mota
    18. Sarah E. Beck
    19. Jacqueline Brockhurst
    20. Alicia Braxton
    21. Natalie Castell
    22. Franco R. D’Alessio
    23. Kelly A. Metcalf Pate
    24. Petros C. Karakousis
    25. Joseph L. Mankowski
    26. Andrew Pekosz
    27. Sanjay K. Jain
    28. Sabra L. Klein
    29. for the Johns Hopkins COVID-19 Hamster Study Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. In vitro evaluation of the activity of terpenes and cannabidiol against Human Coronavirus E229

    1. Lior Chatow
    2. Adi Nudel
    3. Iris Nesher
    4. David Hayo Hemo
    5. Perri Rozenberg
    6. Hanna Voropaev
    7. Ilan Winkler
    8. Ronnie Levy
    9. Zohar Kerem
    10. Zohara Yaniv
    11. Nadav Eyal

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. MARCH8 targets cytoplasmic lysine residues of various viral envelope glycoproteins

    1. Yanzhao Zhang
    2. Seiya Ozono
    3. Takuya Tada
    4. Minoru Tobiume
    5. Masanori Kameoka
    6. Satoshi Kishigami
    7. Hideaki Fujita
    8. Kenzo Tokunaga

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Rapid Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Tungsten Trioxide-Based (WO 3 ) Photocatalysis

    1. Silvia Ghezzi
    2. Isabel Pagani
    3. Guido Poli
    4. Stefano Perboni
    5. Elisa Vicenzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Evaluation of the SARS-CoV-2 inactivation efficacy associated with buffers from three kits used on high-throughput RNA extraction platforms

    1. Ruth E. Thom
    2. Lin S. Eastaugh
    3. Lyn M. O’Brien
    4. David O. Ulaeto
    5. James S. Findlay
    6. Sophie J. Smither
    7. Amanda L. Phelps
    8. Helen L. Stapleton
    9. Karleigh A. Hamblin
    10. Simon A. Weller

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Immunization with the receptor–binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement

    1. Jinkai Zang
    2. Chenjian Gu
    3. Bingjie Zhou
    4. Chao Zhang
    5. Yong Yang
    6. Shiqi Xu
    7. Xueyang Zhang
    8. Yu Zhou
    9. Lulu Bai
    10. Yang Wu
    11. Zhiping Sun
    12. Rong Zhang
    13. Qiang Deng
    14. Zhenghong Yuan
    15. Hong Tang
    16. Di Qu
    17. Dimitri Lavillette
    18. Youhua Xie
    19. Zhong Huang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

    1. Yiska Weisblum
    2. Fabian Schmidt
    3. Fengwen Zhang
    4. Justin DaSilva
    5. Daniel Poston
    6. Julio C. C. Lorenzi
    7. Frauke Muecksch
    8. Magdalena Rutkowska
    9. Hans-Heinrich Hoffmann
    10. Eleftherios Michailidis
    11. Christian Gaebler
    12. Marianna Agudelo
    13. Alice Cho
    14. Zijun Wang
    15. Anna Gazumyan
    16. Melissa Cipolla
    17. Larry Luchsinger
    18. Christopher D. Hillyer
    19. Marina Caskey
    20. Davide F. Robbiani
    21. Charles M. Rice
    22. Michel C. Nussenzweig
    23. Theodora Hatziioannou
    24. Paul D. Bieniasz

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity

  9. Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples

    1. Abhijith Biji
    2. Oyahida Khatun
    3. Shachee Swaraj
    4. Rohan Narayan
    5. Raju Rajmani
    6. Rahila Sardar
    7. Deepshikha Satish
    8. Simran Mehta
    9. Hima Bindhu
    10. Madhumol Jeevan
    11. Deepak K Saini
    12. Amit Singh
    13. Dinesh Gupta
    14. Shashank Tripathi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity

    1. Lei Bai
    2. Yongliang Zhao
    3. Jiazhen Dong
    4. Simeng Liang
    5. Ming Guo
    6. Xinjin Liu
    7. Xin Wang
    8. Zhixiang Huang
    9. Xiaoyi Sun
    10. Zhen Zhang
    11. Lianghui Dong
    12. Qianyun Liu
    13. Yucheng Zheng
    14. Danping Niu
    15. Min Xiang
    16. Kun Song
    17. Jiajie Ye
    18. Wenchao Zheng
    19. Zhidong Tang
    20. Mingliang Tang
    21. Yu Zhou
    22. Chao Shen
    23. Ming Dai
    24. Li Zhou
    25. Yu Chen
    26. Huan Yan
    27. Ke Lan
    28. Ke Xu

    Reviewed by ScreenIT

    2 evaluationsAppears in 1 listLatest version Latest activity
Previous Page 227 of 252 Next